EEG-brain mapping in schizophrenics with predominantly positive and negative symptoms Comparative studies with remoxipride/haloperidol

[1]  T. Itil,et al.  EEG findings in chronic schizophrenics based on digital computer period analysis and analog power spectra. , 1972, Biological psychiatry.

[2]  S. Yanagisawa,et al.  ISOCHROMOSOME X ASSOCIATED WITH PARACENTRIC INVERSION , 1973 .

[3]  S. Mednick,et al.  Computer EEG and auditory evoked potential investigations in children at high risk for schizophrenia. , 1974, The American journal of psychiatry.

[4]  D. Ingvar,et al.  ABNORMALITIES OF CEREBRAL BLOOD FLOW DISTRIBUTION IN PATIENTS WITH CHRONIC SCHIZOPHRENIA , 1974, Acta psychiatrica Scandinavica.

[5]  T. Crow,et al.  CEREBRAL VENTRICULAR SIZE AND COGNITIVE IMPAIRMENT IN CHRONIC SCHIZOPHRENIA , 1976, The Lancet.

[6]  M. Taylor,et al.  Differential EEG patterns in affective disorder and schizophrenia. , 1979, Archives of general psychiatry.

[7]  N C Andreasen,et al.  Thought, language, and communication disorders. II. Diagnostic significance. , 1979, Archives of general psychiatry.

[8]  T. Crow,et al.  Molecular pathology of schizophrenia: more than one disease process? , 1980, British medical journal.

[9]  F. Duffy,et al.  Significance probability mapping: an aid in the topographic analysis of brain electrical activity. , 1981, Electroencephalography and clinical neurophysiology.

[10]  E. Serafetinides,et al.  Schizophrenic symptomatology and cerebral dominance patterns: a comparison of EEG, AER, and BPRS measures. , 1981, Comprehensive psychiatry.

[11]  N C Andreasen,et al.  Negative v positive schizophrenia. Definition and validation. , 1982, Archives of general psychiatry.

[12]  S. R. Hirsch,et al.  15O POSITRON EMISSION TOMOGRAPHIC SCANNING IN PREDOMINANTLY NEVER-TREATED ACUTE SCHIZOPHRENIC PATIENTS , 1983, The Lancet.

[13]  H. Hall,et al.  Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain. , 1984, European journal of pharmacology.

[14]  H. Meltzer,et al.  Negative symptoms and platelet monoamine oxidase activity in male schizophrenic patients , 1984, Psychiatry Research.

[15]  B. Saletu,et al.  [Clinical psychodiagnosis using psychophysiologic procedures]. , 1984, Wiener medizinische Wochenschrift.

[16]  T. Crow,et al.  The two-syndrome concept: origins and current status. , 1985, Schizophrenia bulletin.

[17]  P. Anderer,et al.  Quantitative EEG, SPEM, and Psychometric Studies in Schizophrenics before and during Differential Neuroleptic Therapy , 1986, Pharmacopsychiatry.

[18]  P. Williamson,et al.  Frontal spectral EEG findings in acutely Ill schizophrenics , 1987, Biological Psychiatry.

[19]  B Saletu,et al.  Topographic brain mapping of EEG in neuropsychopharmacology--Part I. Methodological aspects. , 1987, Methods and findings in experimental and clinical pharmacology.

[20]  E. John,et al.  Neurometrics: computer-assisted differential diagnosis of brain dysfunctions. , 1988, Science.

[21]  P. Rondot,et al.  Bilateral brain dysfunction during motor activation in type II schizophrenia measured by EEG mapping , 1988, Biological Psychiatry.

[22]  B. Saletu,et al.  Pharmacodynamic studies of a combination of lorazepam and diphenhydramine and its single components: psychometric and psychophysiological data , 1988 .

[23]  [Computer-assisted determination of rigidity in the differentiation of psychopathologic groups]. , 1988, Wiener medizinische Wochenschrift.

[24]  J. Gruzelier,et al.  The Neuropsychology of Schizophrenia in the Context of Topographical Mapping of Electrocortical Activity , 1989 .

[25]  L. DeLisi,et al.  Increased temporal lobe glucose use in chronic schizophrenic patients , 1989, Biological Psychiatry.

[26]  H. Petsche,et al.  Coherence Mapping Reveals Differences in the EEG Between Psychiatric Patients and Healthy Persons , 1989 .

[27]  C. Nahmias,et al.  Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia , 1989, Psychiatry Research.